ucb sa (UCB:EN Brussels)
Transactions by UCB SA (UCB) in the last 6 months
Dermira Inc. announced that it has received $51 million in series C round of funding on August 19, 2014. The transaction included participation from existing investors Bay City Capital LLC, New Enterprise Associates, Canaan Partners, and UCB SA and new investors Apple Tree Partners, Aisling Capital, Rock Springs Capital, and Sabby Capital. The transaction also included participation from other healthcare investors. Leerink Partners LLC acted as the exclusive placement ...
Apple Tree Partners
Bay City Capital LLC
New Enterprise Associates
Rock Springs Capital
Dermira Inc. announced that it has received $5 million in equity funding from new investor UCB SA on July 3, 2014. The investor has made a commitment to invest up to an additional $15 million in the future equity findings.
UCB SA (ENXTBR:UCB) acquired an unknown minority stake in Beryllium LLC on May 20, 2014. Neil Weir, UCB New Medicines' Senior Vice President joined Beryllium's Board of Directors.
|Grifols SA||€32.56 EUR||-0.125|
|Hospira Inc||$52.14 USD||-0.32|
|Mylan Inc/PA||$46.61 USD||+0.08|
|Sigma-Aldrich Corp||$135.77 USD||-0.63|
|Valspar Corp/The||$79.60 USD||-0.58|
|View Industry Companies|